A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

Accuracy is each model's performance compared to that of a medical grade thermometer. Readings were taken on adults without fever. Two buttons for basic operation. Has memory recall, with up to 10 ...